The Supreme Court Wednesday once again asked pharma company Novartis to scale down the price of its cancer drug Glivec, made from compound imatinib mesylate.
The Supreme Court today asked Swiss pharma giant Novartis AG whether it should not sell its anti-cancer drug for Rs 5 each to benefit common man.
Day in Pics: 20th December
Showbiz World - December 20, 2014
People Magazine Awards 2014